Johnson & Johnson today said second-quarter profit jumped on strong demand for its prescription medicines and medical devices.
The diversified health-care company, based in New Brunswick, New Jersey, said it earned $2.68 billion, or 89 cents per share, compared with $2.46 billion, or 82 cents per share, a year earlier.
Excluding special items, the company said it earned 93 cents per share. Analysts, on average, expected 91 cents per share, according estimates.
